Back

Discovery of Selective Nrf2 Activators from Natural Products: AComputational Screening Approach to Minimize Off-Target Effects on PXR and CYP2D6

Wang, Y.; Gong, Y.; Li, R.; Li, Z.; Cai, H.; Fan, L.; Ma, H.

2026-04-15 bioinformatics
10.64898/2026.04.12.718057 bioRxiv
Show abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a central regulator of cellular antioxidant responses and a highly promising therapeutic target for a range of oxidative stress-related diseases. However, the clinical translation of Nrf2 activators has been hampered by significant off-target effects--notably unintended activation of the pregnane X receptor (PXR) and inhibition of cytochrome P450 2D6 (CYP2D6)--which can lead to dangerous drug-drug interactions and metabolic complications. To overcome this critical barrier, we conducted the first large-scale computational screening of 628,898 natural products from the COCONUT database, integrating molecular docking with a rigorous three-tier selectivity strategy designed to prioritize compounds that strongly bind KEAP1 (the primary Nrf2 repressor) while minimizing interactions with PXR and CYP2D6. Our innovative approach identified 10 ultraselective candidates that demonstrate potent KEAP1 affinity, negligible PXR engagement, and only moderate CYP2D6 binding--achieving up to 12.29-fold selectivity for Nrf2 pathway activation. These top hits are structurally novel, enriched in lipid-like and nucleoside-inspired scaffolds, and exhibit promising drug-like properties. By providing both a curated set of chemically diverse, selectivity-optimized leads and a publicly accessible screening dataset, this work establishes a new foundation for the rational development of safer, more precise Nrf2-targeted therapies, bridging a crucial gap between target potential and clinical viability. By prioritizing compounds with minimal off-target effects on PXR and CYP2D6, our approach offers a scalable template for reducing drug development failures and advancing safer therapeutics for oxidative stress-related diseases. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=124 SRC="FIGDIR/small/718057v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@13c6c79org.highwire.dtl.DTLVardef@1f5a078org.highwire.dtl.DTLVardef@fa4f4borg.highwire.dtl.DTLVardef@16bc881_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical abstractC_FLOATNO C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 11%
14.4%
2
Advanced Science
249 papers in training set
Top 1%
10.1%
3
Journal of Medicinal Chemistry
68 papers in training set
Top 0.2%
6.4%
4
Chemical Science
71 papers in training set
Top 0.1%
6.3%
5
Journal of Chemical Information and Modeling
207 papers in training set
Top 1.0%
4.9%
6
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.1%
4.0%
7
Cell Chemical Biology
81 papers in training set
Top 0.7%
3.7%
8
Journal of the American Chemical Society
199 papers in training set
Top 2%
3.6%
50% of probability mass above
9
Nature Chemical Biology
104 papers in training set
Top 1.0%
2.9%
10
eLife
5422 papers in training set
Top 31%
2.7%
11
ACS Central Science
66 papers in training set
Top 0.6%
2.7%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 25%
2.6%
13
Communications Chemistry
39 papers in training set
Top 0.1%
2.1%
14
ACS Chemical Biology
150 papers in training set
Top 0.8%
1.9%
15
Nucleic Acids Research
1128 papers in training set
Top 11%
1.7%
16
Advanced Therapeutics
15 papers in training set
Top 0.2%
1.3%
17
iScience
1063 papers in training set
Top 19%
1.3%
18
The Journal of Physical Chemistry Letters
58 papers in training set
Top 1%
1.2%
19
Nature
575 papers in training set
Top 14%
1.0%
20
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
21
Nature Biotechnology
147 papers in training set
Top 7%
0.9%
22
Computational and Structural Biotechnology Journal
216 papers in training set
Top 7%
0.9%
23
Science Advances
1098 papers in training set
Top 28%
0.8%
24
Small
70 papers in training set
Top 1%
0.8%
25
ACS Medicinal Chemistry Letters
16 papers in training set
Top 0.5%
0.8%
26
Molecules
37 papers in training set
Top 2%
0.8%
27
PLOS ONE
4510 papers in training set
Top 67%
0.7%
28
ACS Omega
90 papers in training set
Top 4%
0.7%
29
Bioorganic & Medicinal Chemistry Letters
10 papers in training set
Top 0.4%
0.7%
30
JACS Au
35 papers in training set
Top 1%
0.7%